NCT06428890Completed
Effect of 7 Days of Grape Seed Extract Supplementation on Cold Pressor Test and Muscle Metaboreflex in Individuals With Elevated and Stage 1 Hypertension
Source: ClinicalTrials.gov · Last updated 24 May 2024
Brief summary (registry, in English)
This study aimed to assess the effect of the supplementation with grape seed extract (GSE) on blood pressure during static handgrip exercise and muscle metaboreflex in individuals with elevated and state 1 hypertension.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 15 May 2024
- Start date
- 1 Mar 2022
- Primary completion date
- 1 Apr 2024
- Lead sponsor
- California Baptist University
- Diseases
- High blood pressure
- NCT number
- NCT06428890
What you commit to
- Study type: Interventional
- Participants enrolled: 12
- From 1 Mar 2022 to the primary completion date, 1 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- taking medications that could affect cardiovascular function or BP
Who the study is looking for
- systolic blood pressure: 120-139 mmHg and/or a diastolic blood pressure: 80-89 mmHg
Age in the registry: 18 years to 30 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| California Baptist University Coordinator of this site? Confirm its status | Riverside | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.